Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 10-Jun-20 11:22 AM View:  | Stemline Therapeutics Inc (STML) | 10-Jun-20 | Grant | 45,000 | -- | -- | 16% 282.88K to 327.88K | |
| 10-Jun-20 11:22 AM View: | Stemline Therapeutics Inc (STML) | 10-Jun-20 | Disposition (change in control) | 327,878 | -- | -- | (100%) 327.88K to 0 | |
| 03-Apr-20 9:31 PM View: | Stemline Therapeutics Inc (STML) | 01-Apr-20 | Sale | 11,524 | $4.79 | $55,200.00 | (4%) 294.4K to 282.88K | |
| 20-Mar-20 9:30 PM View: | Stemline Therapeutics Inc (STML) | 16-Mar-20 | Sale | 2,849 | $3.88 | $11,054.10 | (< 1%) 319.73K to 316.88K | |
| 13-Mar-20 9:31 PM View: | Stemline Therapeutics Inc (STML) | 10-Mar-20 | Sale | 8,846 | $4.92 | $43,522.30 | (3%) 328.58K to 319.73K | |
| 13-Mar-20 9:31 PM View: | Stemline Therapeutics Inc (STML) | 09-Mar-20 | Sale | 5,011 | $5.08 | $25,455.90 | (2%) 333.59K to 328.58K | |
| 28-Feb-20 9:32 PM View: | Stemline Therapeutics Inc (STML) | 25-Feb-20 | Sale | 9,147 | $6.43 | $58,815.20 | (3%) 342.74K to 333.59K | |
| 14-Feb-20 9:28 PM View: | Stemline Therapeutics Inc (STML) | 10-Feb-20 | Grant | 107,317 | -- | -- | 46% 235.42K to 342.74K | |
| 03-Jan-20 5:18 PM View: | Stemline Therapeutics Inc (STML) | 27-Dec-19 | Sale | 197 | $10.48 | $2,064.56 | (< 1%) 235.62K to 235.42K | |
| 03-Jan-20 5:18 PM View: | Stemline Therapeutics Inc (STML) | 26-Dec-19 | Sale | 1,511 | $10.75 | $16,243.20 | (< 1%) 237.13K to 235.62K | |
| 03-Jan-20 5:18 PM View: | Stemline Therapeutics Inc (STML) | 24-Dec-19 | Sale | 2,388 | $10.97 | $26,196.40 | (< 1%) 239.52K to 237.13K | |
| 03-Jan-20 5:18 PM View: | Stemline Therapeutics Inc (STML) | 23-Dec-19 | Sale | 421 | $10.58 | $4,454.18 | (< 1%) 239.94K to 239.52K | |
| 17-May-19 9:29 PM View: | Stemline Therapeutics Inc (STML) | 03-May-19 | Grant | 15,000 | -- | -- | 7% 224.94K to 239.94K | |
| 15-Mar-19 9:00 PM View: | Stemline Therapeutics Inc (STML) | 12-Mar-19 | Market Sale | 530 | $11.05 | $5,856.50 | (< 1%) 225.47K to 224.94K | (22%) |
| 15-Mar-19 9:00 PM View: | Stemline Therapeutics Inc (STML) | 11-Mar-19 | Market Sale | 13,492 | $11.11 | $149,896.00 | (6%) 238.96K to 225.47K | (21%) |
| 08-Mar-19 9:30 PM View: | Stemline Therapeutics Inc (STML) | 07-Mar-19 | Market Sale | 1,381 | $11.32 | $15,632.90 | (< 1%) 240.34K to 238.96K | 3% |
| 27-Feb-19 9:10 PM View: | Stemline Therapeutics Inc (STML) | 25-Feb-19 | Market Sale | 8,563 | $12.03 | $103,013.00 | (3%) 248.9K to 240.34K | 2% |
| 08-Feb-19 8:50 PM View: | Stemline Therapeutics Inc (STML) | 06-Feb-19 | Grant | 78,559 | -- | -- | 46% 170.34K to 248.9K | |
| 08-Feb-19 8:50 PM View: | Stemline Therapeutics Inc (STML) | 21-Dec-18 | Grant | 15,000 | -- | -- | 10% 155.34K to 170.34K | |
| 14-Mar-18 9:30 PM View: | Stemline Therapeutics Inc (STML) | 12-Mar-18 | Market Sale | 9,183 | $17.38 | $159,595.00 | (5%) 189.87K to 180.68K | 34% |
| 09-Mar-18 9:31 PM View: | Stemline Therapeutics Inc (STML) | 08-Mar-18 | Grant | 37,592 | -- | -- | 25% 152.28K to 189.87K | |
| 09-Mar-18 9:31 PM View: | Stemline Therapeutics Inc (STML) | 07-Mar-18 | Market Sale | 1,413 | $16.56 | $23,399.30 | (< 1%) 153.69K to 152.28K | 31% |
| 28-Feb-18 9:32 PM View: | Stemline Therapeutics Inc (STML) | 27-Feb-18 | Market Sale | 4,584 | $17.26 | $79,119.80 | (3%) 158.14K to 153.55K | 33% |
| 28-Feb-18 9:32 PM View: | Stemline Therapeutics Inc (STML) | 26-Feb-18 | Market Sale | 4,400 | $17.61 | $77,484.00 | (3%) 162.54K to 158.14K | 35% |
| 19-Jan-18 9:30 PM View: | Stemline Therapeutics Inc (STML) | 17-Jan-18 | Market Sale | 4,250 | $13.43 | $57,077.50 | (3%) 166.79K to 162.54K | 14% |
| 09-Mar-17 9:34 PM View: | Stemline Therapeutics Inc (STML) | 09-Mar-17 | Grant | 70,299 | -- | -- | 73% 95.91K to 166.21K | |
| 09-Mar-17 9:34 PM View: | Stemline Therapeutics Inc (STML) | 07-Mar-17 | Market Sale | 1,116 | $8.13 | $9,073.08 | (1%) 97.03K to 95.91K | (41%) |
| 01-Mar-17 9:52 PM View: | Stemline Therapeutics Inc (STML) | 28-Feb-17 | Market Sale | 2,986 | $7.01 | $20,931.90 | (3%) 99.89K to 96.91K | (64%) |
| 01-Mar-17 9:52 PM View: | Stemline Therapeutics Inc (STML) | 27-Feb-17 | Market Sale | 3,500 | $6.97 | $24,395.00 | (3%) 103.39K to 99.89K | (65%) |
| 24-Jan-17 7:49 PM View: | Stemline Therapeutics Inc (STML) | 19-Jan-17 | Market Sale | 3,593 | $11.46 | $41,175.80 | (3%) 106.98K to 103.39K | (< 1%) |
| 10-Mar-16 8:54 PM View: | Stemline Therapeutics Inc (STML) | 08-Mar-16 | Market Sale | 1,148 | $5.32 | $6,107.36 | (1%) 107.61K to 106.47K | (105%) |
| 26-Feb-16 10:00 PM View: | Stemline Therapeutics Inc (STML) | 24-Feb-16 | Grant | 72,023 | -- | -- | 204% 35.24K to 107.27K | |
| 21-Jan-16 6:06 PM View: | Stemline Therapeutics Inc (STML) | 20-Jan-16 | Market Sale | 46 | $4.69 | $215.74 | (< 1%) 35.29K to 35.24K | (133%) |
| 21-Jan-16 6:06 PM View: | Stemline Therapeutics Inc (STML) | 19-Jan-16 | Market Sale | 3,171 | $4.82 | $15,284.20 | (8%) 38.46K to 35.29K | (127%) |
| 10-Mar-15 5:54 PM View: | Stemline Therapeutics Inc (STML) | 06-Mar-15 | Grant | 11,569 | -- | -- | 43% 26.69K to 38.26K | |
| 21-Jan-15 5:00 PM View: | Stemline Therapeutics Inc (STML) | 20-Jan-15 | Market Sale | 3,311 | $14.22 | $47,082.40 | (11%) 30.0K to 26.69K | 23% |
| 17-Oct-13 11:21 AM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 15-Oct-13 | Market Sale | 47,876 | $0.08 | $3,855.38 | (57%) 83.64K to 35.76K | 29% |
| 08-Mar-13 4:15 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 06-Mar-13 | Market Sale (Planned) | 1,560 | $0.93 | $1,450.80 | (2%) 85.2K to 83.64K | 40% |
| 07-Mar-13 4:51 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 05-Mar-13 | Grant | 29,000 | -- | -- | 52% 56.2K to 85.2K | |
| 27-Jan-11 11:46 AM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 24-Jan-11 | Market Sale (Planned) | 2,032 | $10.00 | $20,320.00 | (2%) 89.33K to 87.3K | 94% |
| 30-Dec-10 11:27 AM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 20-Dec-10 | Market Sale (Planned) | 1,536 | $11.87 | $18,232.60 | (3%) 45.95K to 44.42K | 95% |
| 27-Jan-11 11:46 AM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 30-Nov-10 | Grant | 73 | $10.03 | $732.19 | < 1% 89.26K to 89.33K | |
| 20-Sep-10 4:45 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 16-Sep-10 | Grant | 22,918 | $20.27 | $464,548.00 | 74% 31.16K to 54.07K | (97%) |
| 20-Sep-10 4:45 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 16-Sep-10 | Payment of Exercise | 8,118 | $20.27 | $164,552.00 | (15%) 54.07K to 45.95K | 97% |
| 27-Jan-11 11:46 AM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 31-Aug-10 | Grant | 60 | $11.95 | $717.06 | < 1% 89.2K to 89.26K | |
| 27-Jan-11 11:46 AM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 31-May-10 | Grant | 71 | $10.23 | $726.61 | < 1% 89.13K to 89.2K | |
| 27-Jan-11 11:46 AM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 26-Feb-10 | Grant | 144 | $11.45 | $1,648.73 | < 1% 88.98K to 89.13K | |
| 17-Feb-10 3:45 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 16-Feb-10 | Market Sale (Planned) | 1,253 | $13.81 | $17,299.70 | (4%) 32.41K to 31.16K | 96% |
| 11-Feb-10 3:23 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 09-Feb-10 | Market Sale (Planned) | 2,037 | $12.77 | $26,002.70 | (6%) 34.45K to 32.41K | 95% |
| 22-Dec-09 4:30 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 21-Dec-09 | Market Sale (Planned) | 1,511 | $12.95 | $19,561.40 | (4%) 35.96K to 34.45K | 96% |